Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects

Clinical trial NCT00698568 · COMPLETED

Trial details

NCT number: NCT00698568
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prophylaxis for Herpes Simplex

Start date: 1996-10-01
Primary completion: 1999-04-01
Enrollment: 7460

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.